InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Depreciation & Amortization (CF) (2017 - 2026)

InflaRx (IFRX) posted Depreciation & Amortization (CF) of $102067.9 for Q1 2026, down 3.53% sequentially from $105798.8 in Q4 2025, and down 14.73% YoY from $119705.5 in Q1 2025.

InflaRx (IFRX) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

InflaRx has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $102067.9 in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 14.73% year-over-year to $102067.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $454705.6 (down 10.86% YoY) and the FY2025 annual result came in at $473936.6, down 9.74% from the prior year.
  • Depreciation & Amortization (CF) eased to $102067.9 in Q1 2026 per IFRX's latest filing, from $105798.8 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $172077.9 in Q1 2022 and troughed at $102067.9 in Q1 2026.
  • A 5-year average of $137828.6 and a median of $145824.3 in 2023 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) dropped 23.6% in 2022, then gained 1.72% in 2023.
  • Over 5 years, Depreciation & Amortization (CF) stood at $151276.2 in 2022, then fell by 3.6% to $145824.3 in 2023, then fell by 18.85% to $118333.0 in 2024, then dropped by 10.59% to $105798.8 in 2025, then dropped by 3.53% to $102067.9 in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $102067.9, $105798.8, and $116663.5 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 40.52 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 191.83 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 102,067.95
Mar 31, 2026 102,067.95
Dec 31, 2025 105,798.75
Dec 31, 2025 105,798.75
Sep 30, 2025 116,663.51
Sep 30, 2025 116,663.51
Jun 30, 2025 130,175.36
Jun 30, 2025 130,175.36
Mar 31, 2025 119,705.50
Mar 31, 2025 119,705.50
Dec 31, 2024 118,333.05
Dec 31, 2024 118,333.05
Sep 30, 2024 122,391.07
Sep 30, 2024 122,391.07
Jun 30, 2024 149,669.07
Jun 30, 2024 149,669.07
Mar 31, 2024 134,653.45
Mar 31, 2024 134,653.45
Dec 31, 2023 145,824.29
Dec 31, 2023 145,824.29